诊断和治疗行动性角质炎的诊断和治疗
Janis Raphael Thamm1, Julia Welzel1, Sandra Schuh1
1Department of Dermatology and Allergology, University Hospital Augsburg, Augsburg, Germany.
概括
行动性角质瘤 (AK) 是一种经常发生的皮肤疾病,可能会发展为状细胞癌 (SCC). 像LC-OCT这样的非侵入性成像显示了AK复发和进展的早期检测和监测的希望.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 医疗成像医学成像
背景情况:
- 行动性角质瘤 (AK) 是一种常见的,反复发生的皮肤瘤,有可能转变为侵入性状细胞癌 (SCC).
- 紫外线暴露和免疫抑制是AK发展的主要危险因素.
- 对于预测恶性转变至关重要的角质细胞异型和增殖的组织学评估通常受到侵入性活检方法的限制.
研究的目的:
- 评估非侵入性成像技术在区分AK与其他皮肤疾病 (如恩病和SCC) 的有用性.
- 探索线场共聚焦OCT (LC-OCT) 的潜力,以实时评估表皮增殖分数 (PRO分数).
- 调查高级成像在AK的非侵入性随访中的作用,以早期检测复发或侵入性进展.
主要方法:
- 使用非侵入性成像技术,包括光学连贯断层扫描 (OCT),反射共聚焦显微镜 (RCM) 和线场共聚焦OCT (LC-OCT).
- 使用LC-OCT可视化表皮和乳头皮肤结构以细胞分辨率.
- 评估LC-OCT进行实时PRO分数评估的能力.
主要成果:
- 像OCT,RCM和LC-OCT这样的非侵入性成像技术在区分AK,博文病和SCC之间表现出有效性.
- LC-OCT可实现皮肤层的高分辨率可视化,促进细胞水平的评估.
- 实时PRO得分评估可以通过LC-OCT实现,为传统组织学评估提供一种非侵入性的替代方案.
结论:
- 非侵入性成像,特别是LC-OCT,为诊断复杂的皮肤病变和评估表皮变化提供了有价值的工具.
- 由于LC-OCT能够提供非侵入性的实时组织学数据,因此可以改善AK的管理.
- 需要进行进一步的研究,以批判性地评估用于非侵入性AK随访的成像技术的使用,旨在早期检测复发和进展.
更多相关视频
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.2K
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
2.3K
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
